Cytoki Pharma
Latest round
- Series A
Last raised
- May 2021
Total raised
- $45M
Investors
- 4
About Cytoki Pharma
Cytoki Pharma ApS, founded in 2019 and headquartered in Denmark, specializes in developing biologic therapies.Cytoki Pharma focuses on developing innovative therapeutic solutions centered around its lead product, CK-0045, a long-acting IL-22 analogue currently in Phase 2 clinical trials. This product aims to address significant unmet medical needs in metabolic diseases, particularly obesity and type 2 diabetes, as well as conditions characterized by epithelial injury, such as inflammatory bowel disease. By leveraging the innate biology of IL-22, CK-0045 is designed to drive durable disease modification, promote healthy weight loss, and exert broader metabolic effects. The company targets a diverse range of end users, including patients suffering from cardiometabolic diseases and healthcare providers involved in their treatment.Cytoki Pharma's revenue model is structured around the commercialization of its proprietary biologic therapies, particularly the flagship product CK-0045. The company engages in strategic partnerships with healthcare organizations and possibly pharmaceutical distributors to facilitate the delivery of its innovative solutions to end users. Revenue generation is expected to occur through direct sales to healthcare providers or potentially through licensing agreements with larger pharmaceutical firms.00 mn on May 4, 2021, Cytoki Pharma plans to advance its lead program through Phase 1 and Phase 2a clinical testing in Inflammatory Bowel Disease. The company is focused on expanding its presence in both European and North American markets, with plans to enhance its product offerings in response to the treatment needs of cardiometabolic disease patients.
Who invested in Cytoki Pharma
4 investors across 2 rounds
See all investors in Cytoki Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cytoki Pharma
Who invested in Cytoki Pharma?
Cytoki Pharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cytoki Pharma raised?
Cytoki Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cytoki Pharma last raise money?
Cytoki Pharma's most recent round on record is a Series A, in May 2021.
What does Cytoki Pharma do?
Cytoki Pharma ApS, founded in 2019 and headquartered in Denmark, specializes in developing biologic therapies.
Where is Cytoki Pharma headquartered?
Cytoki Pharma is headquartered in Denmark.
Which VCs invest in companies like Cytoki Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Cytoki Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cytoki Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.